Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ADI 2016 | Evaluating the effect of diabetes drug liraglutide for Alzheimer’s disease

Doug Brown • 22 Apr 2016
ADI 2016
Alzheimer’s Disease Liraglutide

At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Doug Brown, PhD, from Alzheimer’s Society, London, United Kingdom, discusses the clinical development of liraglutide, a glucagon-like peptide (GLP)-1 receptor agonist, for people with Alzheimer’s disease.

More from Doug Brown

Introducing Alzheimer Society, a UK dementia support and research charity
1:30
Introducing Alzheimer Society, a UK dementia support and research charity
Doug Brown • 22 Apr 2016
An update on disease-modifying treatments for dementia
1:27
An update on disease-modifying treatments for dementia
Doug Brown • 22 Apr 2016

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
MenoCog: risk and protective factors for cognitive function in the menopause transition
2:37
MenoCog: risk and protective factors for cognitive function in the menopause transition
Amber Watts • 14 Jul 2026
What are the biological mechanisms underlying the higher prevalence of AD in women?
1:55
What are the biological mechanisms underlying the higher prevalence of AD in women?
Amber Watts • 14 Jul 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals